Asborin: The carbaborane analogue of aspirin

ChemMedChem

Volumn 4, Issue 5, 2009, Pages 746-748

  Scholz, Matthias ^a   Bensdorf, Kerstin ^b   Gust, Ronald ^b   Hey Hawkins, Evamarie ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Aspirin analogues; Carbaboranes; Cluster compounds; Drug design; Inhibitors

Indexed keywords

1 HYDROXY 1,2 DICARBA CLOSO DODECABORANE; 1 HYDROXY 1,2 DICARBA CLOSO DODECABORANE 2 CARBOXYLIC ACID; ACETYLSALICYLIC ACID; ACETYLSALICYLIC ACID DERIVATIVE; ASBORIN; CARBON; CARBOXYLIC ACID; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; NONSTEROID ANTIINFLAMMATORY AGENT; PERACETIC ACID; PROSTAGLANDIN H2; PROTON; UNCLASSIFIED DRUG; ACETIC ACID DERIVATIVE; BORON DERIVATIVE; DRUG DERIVATIVE; PROSTAGLANDIN SYNTHASE INHIBITOR;

ANIMAL CELL; ARTICLE; ATOM; CARBON NUCLEAR MAGNETIC RESONANCE; CARBOXYLATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CRYSTAL STRUCTURE; DRUG MECHANISM; DRUG STRUCTURE; DRUG SYNTHESIS; ELECTROSPRAY MASS SPECTROMETRY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; NONHUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; X RAY CRYSTALLOGRAPHY; CHEMISTRY; METABOLISM; SYNTHESIS;

ACETATES; ASPIRIN; BORON COMPOUNDS; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE INHIBITORS;

EID: 67651102934     PISSN: 18607179     EISSN: 18607187     Source Type: Journal    
DOI: 10.1002/cmdc.200900072     Document Type: Article

References (19)

1. J. R. Vane, R. J. Flower, R. M. Botting, Stroke 1990, 21 (12 Suppl.), IV 12.
2. a) J. J. Killackey, B. A. Killackey, I. Cerskus, R. B. Philp, Inflammation 1984, 8, 157;
3. b) S. E. Massil, G. Y. Shi, I. M. Klotz, J. Pharm. Sci. 1984, 73, 1851;
4. c) P. J. Loll, C. T. Sharkey, S. J. O'Connor, C. M. Dooley, E. O'Brien, M. Devocelle, K. B. Nolan, B. S. Selinsky, D. J. Fitzgerald, Mol. Pharmacol. 2001, 60, 1407;
5. d) H. S. Moon, S. I. Nam, S. D. Kim, D. Kim, B. J. Gwag, Y. A. Lee, S. H. Yoon, J. Pharm. Pharmacol. 2002, 54, 935.
6. R. Epton, G. Marr, G. K. Rogers, J. Organomet. Chem. 1976, 110, C42.
7. J. F. Valliant, P. Schaffer, K. A. Stephenson, J. F. Britten, J. Org. Chem. 2002, 67, 383.
8. R. C. Reynolds, S. R. Campbell, R. G. Fairchild, R. L. Kisliuk, P. L. Micca, S. F. Queener, J. M. Riordan, W. D. Sedwick, W. R. Waud, A. K. Leung, R. W. Dixon, W. J. Suling, D. W. Borhani, J. Med. Chem. 2007, 50, 3283.
9. R. L. Julius, O. K. Farha, J. Chiang, L. J. Perry, M. F. Hawthorne, Proc. Natl. Acad. Sci. USA 2007, 104, 4808.
10. K. Ohta, T. Goto, H. Yamazaki, F. Pichierri, Y. Endo, Inorg. Chem. 2007, 46, 3966.
11. a) R. J. Flower, Nat. Rev. Drug Discovery 2003, 2, 179;
12. b) B. Hinz, K. Brune, J. Pharmacol. Exp. Ther. 2002, 300, 367.
13. a) G. P. Hochgesang, Jr., S. W. Rowlinson, L. J. Marnett, J. Am. Chem. Soc. 2000, 122, 6514;
14. b) M. Lecomte, O. Laneuville, C. Ji, D. L. DeWitt, W. L. Smith, J. Biol. Chem. 1994, 269, 13207.
15. M. V. R. Reddy, M. R. Mallireddigari, V. R. Pallela, P. Venkatapuram, R. Boominathan, S. C. Bell, E. P. Reddy, Bioorg. Med. Chem. 2005, 13, 1715.
16. K. H. Ruan, Mini-Rev. Med. Chem. 2004, 4, 639.
17. SCALE3 ABSPACK: Empirical absorption correction, CrysAlis Software package, Oxford Diffraction Ltd., Oxford (UK) 2006.
18. A. Altomare, G. Cascarano, C. Giacovazzo, A. Guagliardi, J. Appl. Crystallogr. 1993, 26, 343-350.
19. G. M. Sheldrick, SHELXL-97, Program for the Refinement of Crystal Structures, University of Göttingen, Göttingen (Germany) 1997.